Skip to content

The Impact of Symptom Management Nursing Intervention on the QoL of Patients With Advanced Lung Cancer: Mediation of Self-management Efficacy and Regulation of Psychological Resilience

Dahua Hospital, Xuhui District, Shanghai

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07679165
Enrollment
176
Registered
2026-07-01
Start date
2023-06-10
Completion date
2025-12-12
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late Stage Lung Cancer, Mediating Effect, Psychological Resilience, QoL, Self Management Efficacy, Symptom Managemen

Brief summary

Symptom management nursing intervention can improve the self-management efficacy, psychological resilience, and QoL of patients with advanced lung cancer.

Detailed description

Self management efficacy is an important mediating variable in the impact of Symptom management nursing intervention on patients' quality of life. Psychological resilience plays a negative moderating role in the effect of Symptom management nursing intervention. Late stage lung cancer patients with low psychological resilience can obtain more significant self management efficacy and quality of life improvement from Symptom management nursing intervention, and are the key beneficiaries of the intervention.

Interventions

OTHERroutine nursing group

Patients in the routine group were given routine care, including disease monitoring, medication care, diet and nutrition guidance, basic life care, routine health education on admission and discharge, symptomatic treatment of patients' discomfort symptoms, telephone follow-up twice a week to understand the patient's condition, and no systematic and personalized SM nursing intervention.

OTHERstandardized systematic SM nursing group

On the basis of routine nursing, implementation of systematic SM nursing intervention for 8 weeks, the specific content is as follows: (1) The intervention group was established. (2) Baseline assessment and file establishment (within 24 hours of admission).(3) Implementation of core intervention (1st to 8th week).

Sponsors

Jie Zeng
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* According to the diagnostic criteria of primary lung cancer \[9\], the clinical stage was stage ⅢB-Ⅳ * aged 18-75 years old * Karnofsky performance status (KPS) ≥60 and expected survival ≥3 months * Patients had clear consciousness and normal cognitive function, and could complete the questionnaire independently or with the assistance of the researcher * have basic communication skills and can cooperate to complete the whole intervention * Patients or their families informed and signed the consent form.

Exclusion criteria

* primary malignant tumors in other parts * history of severe heart, liver, kidney and other important organ failure, severe infection or mental illness * Unable to cooperate with the study due to cognitive impairment, visual and hearing impairment * participating in other similar nursing intervention studies.

Design outcomes

Primary

MeasureTime frameDescription
Change in Quality of Life as measured by the Functional Assessment of Cancer Therapy-Lung (FACT-L) ScaleBaseline (within 24 hours of admission) and at 8 weeks (immediately post-intervention)The Functional Assessment of Cancer Therapy-Lung (FACT-L) scale will be used to assess changes in quality of life in patients with advanced lung cancer. The scale consists of 36 items across five domains: physical health status, social and family conditions, emotional well-being, functional capability, and lung cancer-specific supplementary concerns. Each item is scored on a 0-4 Likert scale, with total scores ranging from 0 to 144. Higher scores indicate better quality of life. The scale has demonstrated good reliability and validity in Chinese populations (Cronbach's α = 0.88-0.92).

Secondary

MeasureTime frameDescription
Change in Self-Management Efficacy as measured by the Strategies Used by People to Promote Health (SUPPH) ScaleBaseline (within 24 hours of admission) and at 8 weeks (immediately post-intervention)The SUPPH scale will be used to assess changes in disease self-management efficacy. The scale includes 28 items across three dimensions: Positive Attitude, Self-Applied Stress Reduction, and Independent Decision-Making. Each item is scored on a 1-5 Likert scale, with total scores ranging from 28 to 140. Higher scores indicate greater self-management efficacy. The Chinese version has excellent reliability (Cronbach's α = 0.96 for the total scale).
Change in Psychological Resilience as measured by the Connor-Davidson Resilience Scale (CD-RISC)Baseline (within 24 hours of admission) and at 8 weeks (immediately post-intervention)The CD-RISC will be used to assess changes in psychological resilience. The scale measures three dimensions-Tenacity, Self-Improvement, and Optimism-using 25 items. Each item is rated on a 0-4 scale, with total scores ranging from 0 to 100. Higher scores indicate stronger psychological resilience. The Chinese version has demonstrated good reliability (Cronbach's α = 0.91).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026